November 28, 2025 · Form 4 insider transaction
Kramer Kelly A. sold 2,805 shares of Gilead Sciences, Inc. at $127.10 per share, a transaction worth $356.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 27, 2025.